2026 National Summit on Hematologic Cancers: Defining the Standard Where the Guidelines End
Venue: Music City Center, 201 Rep. John Lewis Way South, Nashville, TN, United States
Official conference page for 2026 National Summit on Hematologic Cancers: Defining the Standard Where the Guidelines End. https://binaytara.org/projects/conferences/2026-national-summit-on-hematologic-cancers
About 2026 National Summit on Hematologic Cancers: Defining the Standard Where the Guidelines End


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Day 1: Friday, October 16th, 2026
All timings are in Central Time (CDT, GMT-05:00) time.
Session Chair: Paolo Strati, MD
08:00 AM - 08:15 AM
The Geography of Cellular Therapy – Folashade Otegbeye, MPH, MBChB
08:15 AM - 08:30 AM
The Economics of Innovation – Richard T. Maziarz, MD
08:30 AM - 08:45 AM
Community–Academic Partnerships That Work – Carter Davis, MD
08:45 AM - 09:00 AM
Panel Discussion & Audience Q&A
Moderators:
Paolo Strati, MD
Panelists:
Carter Davis, MD; Richard T. Maziarz, MD; Folashade Otegbeye, MPH, MBChB
09:00 AM - 10:00 AM
Session 2A: Pediatrics - Prevention and Management of Leukemia Relapse
Moderators:
Akshay Sharma, MBBS, M.Sc; Soheil Meshinchi, MD
09:00 AM - 10:00 AM
Session 2B: Adults- The Gray Zone: High-Grade Lymphoma
Moderators:
Andrew Ip, MD; Pierluigi Porcu, MD
Panelists:
Basem M. William, MD
09:00 AM - 10:00 AM
Session 2C: APP & Pharmacist - Balancing Benefit and Burden in Hematologic Malignancies
Moderators:
Rhiannon Dorris, PharmD, BCOP, BCPS; Heena Westlake Kurish, BCOP
Panelists:
Adam DiPippo, PharmD; Nataly Bailey, MSN, NP; Callee Brooks , PharmD, BCOP; Amy Webb, RN, FNP, PhD
10:45 AM - 11:45 AM
Session 3A: Pediatrics - Bone Marrow Failure and MDS in Young
Moderators:
Eneida Rosario Nemecek, MD, MBA, MS; Raul Ribeiro, MD
10:45 AM - 11:45 AM
Session 3B: Adults - The Gray Zone: Controversy and Clinical Judgment in MDS/AML
Moderators:
Martha Mims, MD, PhD
Panelists:
Aref Al-Kali, MD; Eytan Stein, MD; Yasmin Abaza, MD; Stephen Anthony Strickland, MD; Alexander Perl, MD; Sumeet Bhatia, MD, MBBS
10:45 AM - 11:45 AM
Session 3C: APP & Pharmacist - Delivering Bispecific Antibodies and CAR‑T in the Real World
Moderators:
Catherine Marcucci, PA-C; Justine Wilson - Miller, PharmD
Panelists:
Amie Fonder, PA-C; Kathryn E. Kennedy, ARNP; Patricia Bulger, MSN; Sydney Spurgeon , PA-C; Brian Primeaux, PharmD, BCOP
11:45 AM - 12:45 PM
Session 4A: Pediatrics - Biphenotypic Leukemia
Moderators:
Stephen B. Gruber, MD, PhD, MPH; Hiroto Inaba , MD, PhD
11:45 AM - 12:45 PM
Session 4B: Adults - The Gray Zone: Controversy and Clinical Judgment in Newly Diagnosed Multiple Myeloma
Moderators:
Noopur Raje, MD; Sagar Lonial, MD
Panelists:
Muhamed Baljevic, MD; Gurbakhash Kaur, MD; Rajshekhar Chakraborty, MD
11:45 AM - 12:45 PM
Session 4C: Adults - The Gray Zone: Controversy and Clinical Judgment in ALL
Moderators:
Marlise Rachael Luskin, MD
Panelists:
Daniel DeAngelo, MD, PhD; Emily Curran , MD; Ryan Cassaday, MD; Caner Saygin, MD
11:45 AM - 12:45 PM
Session 4D: APP & Pharmacist - Managing Complex Acute Leukemia Cases: Toxicities, Transitions, and Multidisciplinary Coordination
Session Chair: Helen Elisabeth Heslop, MD
02:05 PM - 02:25 PM
The Post–CAR-T Playbook: What Comes Next? – Sattva S Neelapu, MD
02:25 PM - 02:45 PM
Beyond Current CAR-Ts: The Cellular Therapy Arms Race – Helen Elisabeth Heslop, MD
02:45 PM - 03:15 PM
Panel Discussion: Tough Questions, Real Decisions
Moderators:
Helen Elisabeth Heslop, MD
Panelists:
Sattva S Neelapu, MD
Session Chair: Aziz Nazha, MD
03:30 PM - 03:45 PM
AI in Hematology Practice: From pathology to MRD to clinical decision-making – Aziz Nazha, MD
03:45 PM - 04:00 PM
AI-Accelerated Drug Development & Trial Design – Andrew Srisuwananukorn, MD
04:00 PM - 04:15 PM
The “Living Drug” Autopilot - AI in cellular therapy and transplant care – Sandeep Raj, MD
04:15 PM - 04:30 PM
Panel Discussion & Audience Q&A
Moderators:
Aziz Nazha, MD
Panelists:
Andrew Srisuwananukorn, MD; Sandeep Raj, MD
